| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alzamend Neuro, Inc. (ALZN) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. ALZN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 25 | $26.22 | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Ault Milton C III | Director | Sell | 1,851 | $2.07 | $3,825.09 | -100% | -10.3% | - | |
| Dec 19, 2025 | Horne William B. | Director | Sell | 3,333 | $2.12 | $7,058.63 | -100% | -10.4% | - | |
| Oct 23, 2025 | McGrath Lynne Fahey | Director | Sell | 30 | $2.29 | $68.70 | -54.5% | +4.3% | - | |
| Oct 9, 2025 | Ault Milton C III | Director | Sell | 121,791 | $2.42 | $294,548.40 | -76.7% | +0.4% | - | |
| Oct 7, 2025 | Ault Milton C III | Director | Sell | 139,412 | $2.47 | $344,222.01 | -59.5% | -17.7% | - | |
| Oct 3, 2025 | Ault Milton C III | Director | Sell | 123,366 | $2.41 | $296,789.42 | -41.0% | -24.9% | - | |
| Sep 30, 2025 | Ault Milton C III | Director, 10% Owner | Sell | 79,628 | $2.31 | $184,155.62 | -36.2% | -18.1% | - | |
| Sep 25, 2025 | Ault Milton C III | Director, 10% Owner | Sell | 97,006 | $2.34 | $226,923.49 | -48.7% | -13.1% | - | |
| Sep 19, 2025 | Ault Milton C III | Director, 10% Owner | Sell | 77,009 | $2.35 | $180,855.64 | -90.3% | -10.0% | - | |
| Sep 18, 2025 | Ault Milton C III | Director, 10% Owner | Sell | 22,991 | $2.47 | $56,696.42 | -10.7% | -13.7% | - |